SP1 and neoplasm: Thus, the oncogenic-like activity of Sp1, Sp3 and Sp4 and Sp-regulated genes coupled with their overexpression in tumor vs. non-tumor tissue suggests that Sp1, Sp3 and Sp4 are non-oncogene addiction (NOA) genes that are “attractive drug targets” [25].